AntlerA Competitors and Similar CompaniesClear all
AntlerA's competitors and similar companies include BioCryst Pharmaceuticals, Zytoprotec, Assertio and Conifer Point.
 BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Zytoprotec Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach. |  Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. |  Conifer Point Conifer Point is an early-stage drug discovery company focused on creating drug candidates. | ||
Founding Date | Founding Date 2018 | Founding Date 1986 | Founding Date 2007 | Founding Date 1995 | Founding Date 2014 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Durham, US HQ Hoover, US | Locations Wien, AT HQ | Locations Lake Forest, US HQ | Locations Doylestown, US HQ |
Employees | Employees 5 | Employees 14040% increase | Employees N/A | Employees 3058% increase | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) 104.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $118.7m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income $263.9m (FY, 2025) | Net income N/A | Net income ($30.4m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.9m | Total funding raised $ 2.7m | Total funding raised $ 42.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
BioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyZytoprotec
HQ
Wien, AT
Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach.
View companyAssertio
HQ
Lake Forest, US
Employees
30
Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
View companyConifer Point
HQ
Doylestown, US
Employees
11
Conifer Point is an early-stage drug discovery company focused on creating drug candidates.
View company